Tentative Scheduling For Bellwether Trials Complete For Xarelto Lawsuit MDL

BloodThinnerHelp.com reports on the scheduling of the first 4 bellwether trials for Xarelto lawsuit cases that have been selected by Presiding Judge Eldon Fallon of the Eastern District of Louisiana who is the administrator of the current multidistrict litigation (MDL), identified as number 2592, and which encompasses over 2,800 cases. These bellwether cases are designed to provide plaintiffs and their attorneys with a good perspective on how the juries in each of these trials will react to the testimony provided and the evidence presented regarding the allegations being made against the manufacturers of the blood thinner drug Xarelto.

Xarelto is the focus of a very large number of lawsuits that are alleging the drug has put patients using it at a much higher risk for instances of uncontrollable and sometimes fatal bleeding. The current complaints focus on episodes of gastrointestinal bleeding, strokes, blood clots and brain hemorrhages. The defendants named in all the cases are Bayer Healthcare AG and Janssen Pharmaceuticals. Xarelto plaintiffs are also claiming that the manufacturers failed to sufficiently make the public aware of the dangers and risks related to using the drug.

As per information released by the court, the first two of the 4 bellwether cases taken from a bellwether pool of 40 cases that were compiled as a result of Judge Fallon's January 11, 2016, directive, are to be heard in 2017. The first two have been scheduled for trial on February 6th and March 13th. The second two cases are scheduled for April 24th and May 30th. These four bellwether trials will provide attorneys and plaintiffs an idea of what strategy to take in relation to the progress of future lawsuits being heard in court.

The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.